# Minocycline as Adjunctive Treatment for Treatment Resistant Depression

> **NCT03947827** · PHASE3 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 76 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT03947827
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2025-01-07
- **Final completion:** 2025-01-07
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03947827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03947827, "Minocycline as Adjunctive Treatment for Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03947827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*